Pill imprint PRASCO 327 has been identified as Phenylephrine and guaifenesin SR 30 mg / 900 mg.
Guaifenesin/phenylephrine is used in the treatment of cough and nasal congestion; sinus symptoms and belongs to the drug class upper respiratory combinations. Risk cannot be ruled out during pregnancy. Guaifenesin/phenylephrine 30 mg / 900 mg is not subject to the Controlled Substances Act.
See also related documents.
Ads by Google
Letter to Semy
Access to secondary education now, for a sustainable future in Africa!
siemens.com/answers/mandela-school
Images for PRASCO 327 (Phenylephrine and guaifenesin SR 30 mg / 900 mg)
Phenylephrine and guaifenesin SR 30 mg / 900 mg PRASCO 327
Phenylephrine and guaifenesin SR
PRASCO
327
Strength:
30 mg / 900 mg
Color:
White
Shape:
Elliptical / Oval
Availability:
Rx and/or OTC
Drug Class:
Upper respiratory combinations
Pregnancy Category:
C – Risk cannot be ruled out
CSA Schedule:
N – Not a controlled drug
Manufacturer:
Prasco Laboratories